New Jersey to Showcase Biotechnology Assets at BIO International this Month

By Nikki Ouellette, Chief Marketing Officer, Choose New Jersey, Inc. On May 31, 2018

With attendance expected to top 16,000, BIO International 2018 – the largest conference in the world for the biotechnology industry to be held in Boston from June 4-7 – provides a unique opportunity to showcase New Jersey’s assets and demonstrate our leadership in biopharmaceuticals to companies from around the world. It also gives members of the New Jersey delegation the potential to engage in meetings and form partnering opportunities with organizations from 48 states and nearly 75 countries.

Representatives from New Jersey life sciences companies, research universities, trade associations, service providers and state government will be part of the New Jersey delegation this year. Choose New Jersey is partnering with BioNJ and the New Jersey Economic Development Authority to sponsor the 1,500-square-foot New Jersey Pavilion (Booth #1721) at the Boston Convention and Exhibition Center on June 4-7.

New Jersey will be launching Research With NJ at BIO International. The online portal will facilitate access to research expertise and other assets at the state’s higher education institutions, enhancing the visibility of output by the state’s leading research experts and increasing opportunities for collaboration. The portal has been hailed by industry leaders as a giant step forward for New Jersey innovation and a great marketing tool for the state’s life sciences sector.

Recognized as a global leader in life sciences, New Jersey offers biotechnology companies a vibrant ecosystem that can support them at every stage of their growth. Our state gives companies access to an exceptional workforce that makes it easy to recruit top talent, including talent that has deep experience in biopharmaceutical manufacturing and commercialization. In addition, biotechnology companies with a New Jersey location have access to high quality lab space, including incubator, intermediate and larger stand-alone space; attractive incentives, including incentives specifically created to support start-up and early-stage companies; access to venture capital; as well as collaborations with leading biopharmaceutical companies and research universities.

New Jersey is home to the headquarters or major facilities of 13 of the world’s top biopharmaceutical companies, as well as 12 of the world’s top companies for R&D productivity. The state’s dynamic ecosystem also includes more than 3,200 life sciences establishments, including more than 1,500 biotechnology establishments, more than 400 contract research organizations, 120 contract manufacturing companies and world renown research universities.

 

Related Articles: